首页
订购/客服:400-666-5481

KB-0742

    
≥98%

源叶(MedMol)
V45552 一键复制产品信息
2416873-83-9
C16H25N5
287.40
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V45552-1mg
≥98%

¥1320.00

货期:3-5天 - - - -
V45552-5mg
≥98%

¥2590.00

货期:3-5天 - - - -
V45552-10mg
≥98%

¥4190.00

货期:3-5天 - - - -
V45552-25mg
≥98%

¥6700.00

货期:3-5天 - - - -
V45552-50mg
≥98%

¥10700.00

货期:3-5天 - - - -
V45552-100mg
≥98%

¥14100.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: KB-0742 is a potent, selective and orally active CDK9 inhibitor with an IC50 of 6 nM for CDK9/cyclin T1. KB-0742 is selective for CDK9/cyclin T1 with >50-fold selectivity over other CDK kinases. KB-0742 has potent anti-tumor activity.
靶点: CDK9/cyclinT1:6 nM (IC50); cdk2/cyclin A:397 nM (IC50); Cdk5/p25:1820 nM (IC50); CDK7/cyclin H:1510 nM (IC50); CDK3/Cyclin E:1420 nM (IC50); CDK1/cyclin A:2980 nM (IC50)
体外研究: KB-0742 (3-30 mg/kg; p.o.; daily; over 21 days) is well tolerated even at high dose, while significantly reducing tumor burden in 22Rv1 human prostate cancer cell line-derived xenograft (CDX) models.
体内研究: KB-0742 (6 hours; 0.1-10 μM; 22Rv1 cells) treatment significant reduction of downstream phosphorylation of RNA Pol II at Ser2 and Ser7, and diminished phosphorylation at Ser5. Global androgen receptor (AR)-FL and AR-V protein levels are significantly reduced starting at 6 h treatment time, which is accompanied by the reduction of phospho-AR levels (Ser81).
KB-0742 (48-72 hours) treatment shows cytostatic effects in prostate cancer and leukemia cell lines. KB-0742 shows antiproliferative activity with GR50s of 0.183 μM and 0.288 μM for 22Rv1 cells and MV-4-11 AML cells, respectively.
In 22Rv1 cells, KB-0742 rapidly downregulates nascent transcription, preferentially depleting short half-life transcripts and AR-driven oncogenic programs.
参考文献: 1. André Richters, et al. Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors. Cell Chem Biol. 2020 Oct 20;S2451-9456(20)30380-9.
2. Freeman DB, et al. Discovery of KB-0742, a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 for MYC-Dependent Cancers. J Med Chem. 2023 Dec 14;66(23):15629-15647.
 
保存条件: -20°C
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 3.479 ml 17.397 ml 34.795 ml
5 mM 0.696 ml 3.479 ml 6.959 ml
10 mM 0.348 ml 1.74 ml 3.479 ml
50 mM 0.07 ml 0.348 ml 0.696 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×